ClinicalTrials.gov
public full text
Public Domain
Galantamine and CBT4CBT Pilot to Prevent Relapse.
The investigators are proposing a randomized pilot feasibility study to evaluate the effects of galantamine versus placebo on preventing relapse to opioid use following tapering from methadone or buprenorphine maintenance (Medication Assisted Treatment, or MAT) among adults with opioid use disorder, with additional behavioral therapy (web-based cognitive behavioral therapy) provided across all conditions to help individuals successfully transition from MAT to a drug-free state.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1#874018
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3#994775
- Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults#872305
- Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients#981413
- Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy#995502
Record · ID 902658
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive